Jump to ContentJump to Main Navigation

Online

Open Access
* Prices subject to change. Shipping costs will be added if applicable.
ISSN:
2084-8854

See all formats and pricing

Online
Open Access
*Prices subject to change. Shipping costs will be added if applicable.

Systems Pharmacology

1 Issue per year

DE GRUYTER OPEN

Emerging Science

Open Access

Systems Pharmacology is closed for submissions and will be discontinued effective April 1, 2014.

Systems Pharmacology (SP) is a peer-reviewed online journal that publishes full-length papers and timely reviews focused on the analyses, integration, and modeling of single and/or combined natural and/or synthetic small molecules with different molecular and cellular components in different biological models, from in vitro cells culture assays to in vivo assays.

Aims and Scope

Why subscribe and read

Systems Pharmacology is a research area derived from the union of concepts and tools of Systems Biology, Pharmacology sciences, Medicinal Chemistry, and Bioinformatics. Systems Pharmacology seeks to explain how naturals and/or synthetic small molecules interacts with biologic components, allowing to derived models that predicts and explain the behavior and properties of biologic models subjected to those small molecules.

Why submit

Systems Pharmacology covers all aspects of this emerging interdisciplinary field of research, attracting high quality researches in the areas of bioinformatics, chemo-systems biology, systems pharmacology, pharmacogenomics, pharmacoproteomics, integration of drug metabolism and cell signaling, regulatory networks, and drug prospection.

Instructions for Authors

 

Systems Pharmacology is covered by the following services:

  • Celdes
  • CNPIEC
  • EBSCO Discovery Service
  • Google Scholar
  • J-Gate
  • Naviga (Softweco)
  • Primo Central (ExLibris)
  • ReadCube
  • Summon (Serials Solutions/ProQuest)
  • TDOne (TDNet)
  • Ulrich's Periodicals Directory/ulrichsweb
  • WorldCat (OCLC)

Journal Editor
Diego Bonatto, Federal University of Rio Grande do Sul, Brazil 

Editorial Advisory Board
Jurgen Bajorath, University of Bonn, Germany
Chi Hin Cho, The Chinese University of Hong Kong, Hong Kong
Mohamed Diwan M. AbdulHameed, Biotechnology HPC Software Applications Institute (BHSAI), USA
Wojciech Krzyżański, The State University of New York, USA
Avi Ma'ayan, Mount Sinai School of Medicine, New York, USA
Gerald Maggiora, University of Arizona, Tucson, USA
Yasushi Okuno, Kyoto University, Japan
Sylvie Ricard-Blum, University of Lyon, France
Hans Westerhoff, The University of Manchester, UK
Lei Xie, The City University of New York, USA
Shuxing Zhang, The University of Texas, Huston, USA 

Assistant Editors
Sara C. T. dos Santos Domingues, University of Aveiro, Portugal
Amir Handzel, Translational Research, Astellas Pharma Inc., USA
Ali Masoudi-Nejad, University of Tehran, Iran
Thanemozhi G. Natarajan, Georgetown University Medical Center Washington, D.C, USA
Xuewei Wang, Research Scientist, IP & Science section, Thomson Reuters

Contact
Diego Bonatto
dbonatto@versita.com

Versita Ltd.
ul. Solipska 14a/1
02-482 Warsaw, Poland
Phone: +48 22 701 50 15

Please log in or register to comment.